EGFR and non-small cell lung carcinoma: While the VeriStrat proteomic classifier has mainly been used in the setting of NSCLC, a recent study showed prognostic value of VeriStrat for PFS and OS in afatinib (EGFR TKI)-treated recurrent/metastatic HNSCC patients, and OS in methotrexate-treated HNSCC patients.